Related references
Note: Only part of the references are listed.FABP5 enhances malignancies of lower-grade gliomas via canonical activation of NF-κB signaling
Yichang Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Elevation of CXCL1 indicates poor prognosis and radioresistance by inducing mesenchymal transition in glioblastoma
Wahafu Alafate et al.
CNS NEUROSCIENCE & THERAPEUTICS (2020)
microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2
Yuanwen Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/beta-catenin signaling pathway in cervical cancer
Tie Xu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Identification of the kinase STK25 as an upstream activator of LATS signaling
Sanghee Lim et al.
NATURE COMMUNICATIONS (2019)
Functional transcriptomic annotation and protein-protein interaction network analysis identify NEK2, BIRC5, and TOP2A as potential targets in obese patients with luminal A breast cancer
Miriam Nuncia-Cantarero et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Current Challenges and Opportunities in Treating Glioblastoma
Andrea Shergalis et al.
PHARMACOLOGICAL REVIEWS (2018)
PIWIL3/OIP5-AS1/miR-367-3p/CEBPA feedback loop regulates the biological behavior of glioma cells
Xiaobai Liu et al.
THERANOSTICS (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
被撤回的出版物: Targeting NEK2 attenuates glioblastoma growth and radioresistance by destabilizing histone methyltransferase EZH2 (Publication with Expression of Concern. See vol. 130, pg. 5027, 2020) (Retracted article. See vol. 130, pg. 6187, 2020)
Jia Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Overexpression of NIMA-related kinase 2 is associated with poor prognoses in malignant glioma
Huajie Liu et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
NEK2 induces osteoclast differentiation and bone destruction via heparanase in multiple myeloma
M. Hao et al.
LEUKEMIA (2017)
MiR-486-5p negatively regulates oncogenic NEK2 in hepatocellular carcinoma
Shun-Jun Fu et al.
ONCOTARGET (2017)
MicroRNA-128 promotes apoptosis in lung cancer by directly targeting NIMA-related kinase 2
Dejian Zhao et al.
THORACIC CANCER (2017)
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Qian Zhang et al.
CELL (2017)
PKCε inhibits isolation and sternness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P
Bin Huang et al.
CANCER LETTERS (2016)
Targeting NEK2 as a promising therapeutic approach for cancer treatment
Yanfen Fang et al.
CELL CYCLE (2016)
Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling
Evan M. Cherry et al.
MOLECULAR CANCER (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Kinome-wide shRNA Screen Identifies the Receptor Tyrosine Kinase AXL as a Key Regulator for Mesenchymal Glioblastoma Stem-like Cells
Peng Cheng et al.
STEM CELL REPORTS (2015)
Kinase Regulation by Hydrophobic Spine Assembly in Cancer
Jiancheng Hu et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Up-regulation of NEK2 by MicroRNA-128 Methylation is Associated with Poor Prognosis in Colorectal Cancer
Yusuke Takahashi et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Overexpression of the Nek2 Kinase in Colorectal Cancer Correlates With Beta-Catenin Relocalization and Shortened Cancer-Specific Survival
Christopher P. Neal et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
NF-κB Inducing Kinase, a Central Signaling Component of the Non-Canonical Pathway of NF-κB, Contributes to Ovarian Cancer Progression
Masaya Uno et al.
PLOS ONE (2014)
The landscape of kinase fusions in cancer
Nicolas Stransky et al.
NATURE COMMUNICATIONS (2014)
Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma
Krishna P. L. Bhat et al.
CANCER CELL (2013)
Noncanonical NF-κB Activation by the Oncoprotein Tio Occurs Through a Nonconserved TRAF3-Binding Motif
Sarah Jill de Jong et al.
SCIENCE SIGNALING (2013)
On the molecular mechanisms of mitotic kinase activation
Richard Bayliss et al.
OPEN BIOLOGY (2012)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
Alternative splicing controls nuclear translocation of the cell cycle-regulated Nek2 kinase
Wenjuan Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro
Chun-Chi Liang et al.
NATURE PROTOCOLS (2007)
β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870
Chunyang Liang et al.
CELLULAR SIGNALLING (2006)
Rootletin forms centriole-associated filaments and functions in centrosome cohesion
S Bahe et al.
JOURNAL OF CELL BIOLOGY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of Raf-1 signaling by protein kinase C through a mechanism involving Raf kinase inhibitory protein
KC Corbit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The TNF and TNF receptor superfamilies: Integrating mammalian biology
RM Locksley et al.
CELL (2001)
Share Paper
